Real-Life Evaluation of Guselkumab Dosing Interval Adjustments — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Real-Life Evaluation of Guselkumab Dosing Interval Adjustments — Stella

Recruiting

Back to Psoriasis trials

Trial locations(1 site)

France

CHU de Nice, Nice, Alpes Maritimes

Key details

Sponsor

Centre Hospitalier Universitaire de Nice

Enrollment target

~100 participants

Started

October 2025

Primary completion

April 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov